Gain detailed insights into the trading activity of Congress members for Kodiak Sciences on our government trades page. Stay updated on how elected officials are investing in KOD.

Kodiak Sciences - Government Trades

Kodiak Sciences

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Movers_Stocks

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

JNPR

RLGT

RYAM

STGW

Polaris, General Motors And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session

Crude-oil-4-logo

Equities

Eurozone

Commodities

Intraday Update

CTCX

NITO

NMRA

TSLA

Crude Oil Surges 2%; Tesla Shares Plummet

Amazon, Crowdstrike, Autodesk, Dell, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Earnings

$USDT

ABAT

AILE

APTO

ATXS

BNRG

CNTM

EDBL

HSDT

JDZG

LAES

NSANY

ONFO

PHIO

RELI

SIGA

TPIC

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

BABA

BILI

LCID

NVTS

PTVE

REAL

SATL

TIGR

Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday

Analyst sees stock go up

Analyst Color

Biotech

Upgrades

Health Care

Price Target

Analyst Ratings

General

Jefferies upgrades Kodiak Sciences, citing undervaluation and growth potential as Phase 3 trials advance for tarcocimab in retinal diseases.

Eye-Disease Focused Kodiak Sciences Is A Promising &#39;Turnaround Story For 2025&#39;: Analyst Upgrades Stock

Penny Stocks

HALO

It has been about a month since the last earnings report for Kodiak Sciences Inc. (NASDAQ: KOD). Shares have lost about 26.2% in that time frame, underperforming the S&amp;P 500.

Why Is Kodiak Sciences Down 26.2% Since Last Earnings Report?

Small Cap

ABTS

AKAN

ALLG

AVTX

BDRX

BRZE

CERO

CZOO

DTST

DXYZ

GCTS

GMDA

HKIT

Kintara Therapeutics, Inc. - Common Stock

KTRA

MARA

MLKN

MRNO

MSTR

MTTR

MVLA

NCNA

NKLA

NTRB

OTRK

PMEC

PRST

RDDT

SEZL

SMMT

SOBR

STRO

TNXP

UGRO

XXII

Shares of  Kodiak Sciences Inc.  (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss.

Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Global

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday.

Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell 0.08% to 16,385.80. The S&amp;P 500 also rose, gaining, 0.04% to 5,250.38.

US Stocks Flat; Initial Jobless Claims Fall To 210,000

AAGR

APLS

BLUE

BMEA

BPMC

BTBT

CLSK

COMM

CYTO

DISH

DOGZ

EFTR

HIVE

IONM

IPDN

ISUN

JTAI

KROS

KTTA

MINM

Morgan Stanley Capital Protected Notes for S&P 500 Index

NXTP

ONTX

RIOT

SHAK

TRKA

VAPO

VERU

WULF

XFOR

ZLAB

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting &amp; Exposition.

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

AMAT

AMSWA

ATGL

ATKR

BBLG

CHPT

CRIS

GDEV

GLOB

IFBD

MANU

MOBV

MOND

MURA

OPTX

QFIN

ROST

SLDB

SNES

TRVG

TWST

VIGL

VNET

WETG

WLGS

ZENV

ZJYL

Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.

Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Kodiak Sciences Inc

Eastman Kodak Co

KODAL MINERALS PLC by KODAL MINERALS PLC

KODIAK COPPER CORP by KODIAK COPPER CORP.

Kodiak Copper Corp

Kodiak Energy Inc

Kodiak Gas Services Inc

Press Releases

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

Kodiak Sciences to Present at Innovate Retina 2024

Kodiak Sciences to Participate in Upcoming Investor Conferences

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Contracts

Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases

Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Alector

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics


Chris JacobsHouse (R-NY)	$1K - $15K	stock	Sale	Dec 12, 2022	Nov 08, 2022	House
Chris JacobsHouse (R-NY)	$1K - $15K	stock	Purchase	Sep 09, 2022	Jul 18, 2022	House

Government Trades

Kodiak Sciences Inc

top performing KOD trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga